Flexible Subscriptions to Match your Budget and Timeline See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Merck
McKinsey
Boehringer Ingelheim
Mallinckrodt
Express Scripts

Last Updated: January 24, 2022

DrugPatentWatch Database Preview

Drug Price Trends for RIFABUTIN


Email this page to a colleague

« Back to Dashboard

Drug Price Trends for RIFABUTIN

Best Wholesale Price for RIFABUTIN

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available to any customer under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Unit Dates Price Type
MYCOBUTIN 150MG CAP Pfizer, Inc. 00013-5301-17 100 285.32 2.85320 EACH 2022-01-01 - 2022-06-30 Big4
MYCOBUTIN 150MG CAP Pfizer, Inc. 00013-5301-17 100 1245.11 12.45110 EACH 2022-01-01 - 2022-06-30 FSS
RIFABUTIN 150MG CAP Greenstone, LLC 59762-1350-01 100 465.10 4.65100 EACH 2022-01-01 - 2022-01-31 Big4
RIFABUTIN 150MG CAP Greenstone, LLC 59762-1350-01 100 1143.10 11.43100 EACH 2022-01-01 - 2022-01-31 FSS
>Drug Name >Vendor >NDC >Count >Price ($) >Price/Unit ($) >Unit >Dates >Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Harvard Business School
Baxter
Medtronic
McKesson
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.